Kaveh Rayani Selected Research

RPR260243

1/2020

The hERG channel activator, RPR260243, enhances protective IKr current early in the refractory period reducing arrhythmogenicity in zebrafish hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaveh Rayani Research Topics

Disease

2	Cardiac Arrhythmias (Arrythmia) 01/2020 - 12/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2022
1	Alcoholism (Alcohol Abuse) 03/2022
1	Spasm (Spasms) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Long QT Syndrome 01/2020
1	Acidosis 01/2018
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 01/2013

Drug/Important Bio-Agent (IBA)

2	Troponin CIBA 12/2022 - 01/2013
1	CannabidiolIBA 01/2021
1	Ether (Diethyl Ether)IBA 01/2020
1	RPR260243IBA 01/2020
1	dofetilide (Tikosyn)FDA Link 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2019
1	carboxy-seminaphthorhodaminefluorideIBA 01/2018
1	Troponin IIBA 01/2013

Therapy/Procedure

1	Secondary Prevention 03/2022
1	Transcranial Magnetic Stimulation 01/2021